BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 17627302)

  • 1. The antithrombotic potential of selective blockade of talin-dependent integrin alpha IIb beta 3 (platelet GPIIb-IIIa) activation.
    Petrich BG; Fogelstrand P; Partridge AW; Yousefi N; Ablooglu AJ; Shattil SJ; Ginsberg MH
    J Clin Invest; 2007 Aug; 117(8):2250-9. PubMed ID: 17627302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kindlin supports platelet integrin αIIbβ3 activation by interacting with paxillin.
    Gao J; Huang M; Lai J; Mao K; Sun P; Cao Z; Hu Y; Zhang Y; Schulte ML; Jin C; Wang J; White GC; Xu Z; Ma YQ
    J Cell Sci; 2017 Nov; 130(21):3764-3775. PubMed ID: 28954813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rap1 binding to the talin 1 F0 domain makes a minimal contribution to murine platelet GPIIb-IIIa activation.
    Lagarrigue F; Gingras AR; Paul DS; Valadez AJ; Cuevas MN; Sun H; Lopez-Ramirez MA; Goult BT; Shattil SJ; Bergmeier W; Ginsberg MH
    Blood Adv; 2018 Sep; 2(18):2358-2368. PubMed ID: 30242097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A talin mutant that impairs talin-integrin binding in platelets decelerates αIIbβ3 activation without pathological bleeding.
    Stefanini L; Ye F; Snider AK; Sarabakhsh K; Piatt R; Paul DS; Bergmeier W; Petrich BG
    Blood; 2014 Apr; 123(17):2722-31. PubMed ID: 24585775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperative role of the membrane-proximal and -distal residues of the integrin beta3 cytoplasmic domain in regulation of talin-mediated alpha IIb beta3 activation.
    Hato T; Yamanouchi J; Tamura T; Yakushijin Y; Sakai I; Yasukawa M
    J Biol Chem; 2008 Feb; 283(9):5662-8. PubMed ID: 18174155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.
    Schwarz M; Meade G; Stoll P; Ylanne J; Bassler N; Chen YC; Hagemeyer CE; Ahrens I; Moran N; Kenny D; Fitzgerald D; Bode C; Peter K
    Circ Res; 2006 Jul; 99(1):25-33. PubMed ID: 16778135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(IIb)beta(3) conjugated to the cell-penetrating peptide Tat(48-60).
    Dimitriou AA; Stathopoulos P; Mitsios JV; Sakarellos-Daitsiotis M; Goudevenos J; Tsikaris V; Tselepis AD
    Platelets; 2009 Dec; 20(8):539-47. PubMed ID: 19863457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis of filamin binding to integrins and competition with talin.
    Kiema T; Lad Y; Jiang P; Oxley CL; Baldassarre M; Wegener KL; Campbell ID; Ylänne J; Calderwood DA
    Mol Cell; 2006 Feb; 21(3):337-47. PubMed ID: 16455489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct binding of the platelet integrin alphaIIbbeta3 (GPIIb-IIIa) to talin. Evidence that interaction is mediated through the cytoplasmic domains of both alphaIIb and beta3.
    Knezevic I; Leisner TM; Lam SC
    J Biol Chem; 1996 Jul; 271(27):16416-21. PubMed ID: 8663236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Talin is required for integrin-mediated platelet function in hemostasis and thrombosis.
    Petrich BG; Marchese P; Ruggeri ZM; Spiess S; Weichert RA; Ye F; Tiedt R; Skoda RC; Monkley SJ; Critchley DR; Ginsberg MH
    J Exp Med; 2007 Dec; 204(13):3103-11. PubMed ID: 18086863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin alpha IIb beta 3.
    Holmbäck K; Danton MJ; Suh TT; Daugherty CC; Degen JL
    EMBO J; 1996 Nov; 15(21):5760-71. PubMed ID: 8918453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GDF-15 prevents platelet integrin activation and thrombus formation.
    Rossaint J; Vestweber D; Zarbock A
    J Thromb Haemost; 2013 Feb; 11(2):335-44. PubMed ID: 23231375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAP interactions with talin and kindlin promote platelet integrin αIIbβ3 activation and stable fibrinogen binding.
    Kasirer-Friede A; Kang J; Kahner B; Ye F; Ginsberg MH; Shattil SJ
    Blood; 2014 May; 123(20):3156-65. PubMed ID: 24523237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
    Wang WY; Wu YC; Wu CC
    Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Talin does not associate exclusively with alpha 2b beta 3 integrin in activated human platelets.
    Escolar G; Diaz-Ricart M; White JG
    J Lab Clin Med; 1995 May; 125(5):597-607. PubMed ID: 7537787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fluorescence cell biology approach to map the second integrin-binding site of talin to a 130-amino acid sequence within the rod domain.
    Tremuth L; Kreis S; Melchior C; Hoebeke J; Rondé P; Plançon S; Takeda K; Kieffer N
    J Biol Chem; 2004 May; 279(21):22258-66. PubMed ID: 15031296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gα13 Switch Region 2 Relieves Talin Autoinhibition to Activate αIIbβ3 Integrin.
    Schiemer J; Bohm A; Lin L; Merrill-Skoloff G; Flaumenhaft R; Huang JS; Le Breton GC; Chishti AH
    J Biol Chem; 2016 Dec; 291(52):26598-26612. PubMed ID: 27803165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calreticulin-independent regulation of the platelet integrin alphaIIbbeta3 by the KVGFFKR alphaIIb-cytoplasmic motif.
    Reilly D; Larkin D; Devocelle M; Fitzgerald DJ; Moran N
    Platelets; 2004 Feb; 15(1):43-54. PubMed ID: 14985176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Talin-dependent integrin signalling in vivo.
    Petrich BG
    Thromb Haemost; 2009 Jun; 101(6):1020-4. PubMed ID: 19492142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NPIY motif in the integrin beta1 tail dictates the requirement for talin-1 in outside-in signaling.
    Nieves B; Jones CW; Ward R; Ohta Y; Reverte CG; LaFlamme SE
    J Cell Sci; 2010 Apr; 123(Pt 8):1216-26. PubMed ID: 20332112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.